Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 147 No. 3940 (2017)

Survival from methicillin-sensitive Staphylococcus aureus bloodstream infections over 20 years: a cohort of 1328 patients

  • Benedikt J. Wiggli
  • Reno Frei
  • Reto Laffer
  • Sarah Tschudin Sutter
  • Andreas F. Widmer
DOI
https://doi.org/10.4414/smw.2017.14508
Cite this as:
Swiss Med Wkly. 2017;147:w14508
Published
30.09.2017

Summary

PURPOSE

Staphylococcus aureus bloodstream infections (SA BSI) are associated with substantial mortality. The rapid emergence of methicillin-resistant S. aureus (MRSA), known to be associated with worse outcome, may blur advances made regarding mortality attributed to SA BSI caused by methicillin-sensitive S. aureus (MSSA) strains. In the unusual setting of a very low MRSA prevalence institution, we investigated incidence, mortality and trends of BSI caused by MSSA over the last 20 years.

OBJECTIVE

To evaluate and demonstrate trends in incidence and mortality of MSSA BSI as well as risk factors for mortality.

METHODS

Retrospective, observational analysis of the prospective bloodstream infection cohort at the University Hospital Basel between January 1993 and December 2013. All patients with blood cultures positive for MSSA were included. All patients were analysed regarding pertinent demographic, clinical and antimicrobial treatment data. We calculated incidence, temporal trends and mortality of MSSA BSI.

RESULTS

1328 episodes of MSSA BSI were identified, accounting for a yearly incidence ranging from 2.1 to 4.5 per 10 000 patient-days (p = 0.2 for trend). Overall mortality was 19.3% and did not improve over time. Community-acquired MSSA BSI significantly increased over time, while nosocomial cases decreased (p <0.05).

CONCLUSIONS

Mortality related to MSSA BSI remains high and unchanged over the last 20 years. Despite advances in treatment and supportive care in medicine during the last 20 years survival did not improve and, therefore, new approaches are required to lower mortality in MSSA BSI.

References

  1. Laupland KB, Lyytikäinen O, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C, et al., International Bacteremia Surveillance Collaborative. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2013;19(5):465–71. doi:.https://doi.org/10.1111/j.1469-0691.2012.03903.x
  2. Naber CK. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis. 2009;48(s4, Suppl 4):S231–7. doi:.https://doi.org/10.1086/598189
  3. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis. 2004;50(1):59–69. doi:.https://doi.org/10.1016/j.diagmicrobio.2004.05.003
  4. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–17. doi:.https://doi.org/10.1086/421946
  5. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev. 2012;25(2):362–86. doi:.https://doi.org/10.1128/CMR.05022-11
  6. Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2010;31(4):365–73. doi:.https://doi.org/10.1086/651094
  7. Lenz R, Leal JR, Church DL, Gregson DB, Ross T, Laupland KB. The distinct category of healthcare associated bloodstream infections. BMC Infect Dis. 2012;12(1):85. doi:.https://doi.org/10.1186/1471-2334-12-85
  8. Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis. 2008;46(6):799–806. doi:.https://doi.org/10.1086/527389
  9. Cunney RJ, McNamara EB, alAnsari N, Smyth EG. Community and hospital acquired Staphylococcus aureus septicaemia: 115 cases from a Dublin teaching hospital. J Infect. 1996;33(1):11–3.https://doi.org/10.1016/S0163-4453(96)92643-2
  10. Retamar P, López-Prieto MD, Nátera C, de Cueto M, Nuño E, Herrero M, et al.; Sociedad Andaluza de Enfermedades Infecciosas/Sociedad Andaluza de Microbiología y Parasitología Clínica and Red Española de Investigación en Enfermedades Infecciosas (SAEI/SAMPAC/REIPI) Bacteremia Group. Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study. BMC Infect Dis. 2013;13(1):344. doi:.https://doi.org/10.1186/1471-2334-13-344
  11. Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gür D, et al.; EARS-Net Participants (Disease Specific Contact Points for AMR). Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16(11):19819.
  12. Mostofsky E, Lipsitch M, Regev-Yochay G. Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus? J Antimicrob Chemother. 2011;66(10):2199–214. doi:.https://doi.org/10.1093/jac/dkr278
  13. Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M, et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2012;18(9):862–9. doi:.https://doi.org/10.1111/j.1469-0691.2011.03679.x
  14. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53–9. doi:.https://doi.org/10.1086/345476
  15. Wolkewitz M, Frank U, Philips G, Schumacher M, Davey P ; BURDEN Study Group. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother. 2011;66(2):381–6. doi:.https://doi.org/10.1093/jac/dkq424
  16. Yaw LK, Robinson JO, Ho KM. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis. 2014;14(10):967–75. doi:.https://doi.org/10.1016/S1473-3099(14)70876-X
  17. Widmer AF, Lakatos B, Frei R. Strict infection control leads to low incidence of methicillin-resistant Staphylococcus aureus bloodstream infection over 20 years. Infect Control Hosp Epidemiol. 2015;36(6):702–9. doi:.https://doi.org/10.1017/ice.2015.28
  18. Blanc DS, Pittet D, Ruef C, Widmer AF, Mühlemann K, Petignat C, et al. Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. Swiss Med Wkly. 2002;132(17-18):223–9.
  19. Laffer RR, Frei R, Widmer AF. [Epidemiology of septicemias in a university hospital over 5 years]. Schweiz Med Wochenschr. 2000;130(41):1471–8. Article in German.
  20. Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect. 2006;12(4):345–52. doi:.https://doi.org/10.1111/j.1469-0691.2005.01359.x
  21. Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, Kirby A, Tilley R, Török ME, et al.; UK Clinical Infection Research Group. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis. 2011;11(3):208–22. doi:.https://doi.org/10.1016/S1473-3099(10)70285-1
  22. Elzi L, Babouee B, Vögeli N, Laffer R, Dangel M, Frei R, et al. How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. Clin Microbiol Infect. 2012;18(9):E355–61. doi:.https://doi.org/10.1111/j.1469-0691.2012.03964.x
  23. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32. doi:.https://doi.org/10.1016/j.ajic.2008.03.002
  24. Versalovic J, American Society for Microbiology. Manual of clinical microbiology. 10th ed. Washington, DC: ASM Press; 2011.
  25. Benfield T, Espersen F, Frimodt-Møller N, Jensen AG, Larsen AR, Pallesen LV, et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect. 2007;13(3):257–63. doi:.https://doi.org/10.1111/j.1469-0691.2006.01589.x
  26. Asgeirsson H, Gudlaugsson O, Kristinsson KG, Heiddal S, Kristjansson M. Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality. Clin Microbiol Infect. 2011;17(4):513–8. doi:.https://doi.org/10.1111/j.1469-0691.2010.03265.x
  27. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG, Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–61. doi:.https://doi.org/10.1128/CMR.00134-14
  28. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616–87. doi:.https://doi.org/10.1128/CMR.00081-09
  29. Paulsen J, Mehl A, Askim Å, Solligård E, Åsvold BO, Damås JK. Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study. BMC Infect Dis. 2015;15(1):116. doi:.https://doi.org/10.1186/s12879-015-0849-4
  30. Lyytikäinen O, Ruotsalainen E, Järvinen A, Valtonen V, Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis. 2005;24(6):399–404. doi:.https://doi.org/10.1007/s10096-005-1345-3
  31. Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235–44. doi:.https://doi.org/10.1056/NEJMoa1703058

Most read articles by the same author(s)

1 2 > >>